REFERENCES
2. Pereira SF, Goss L, Dworkin J. Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol Mol Biol Rev 2011;75:192-212.
4. Hanks SK, Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase [catalytic] domain structure and classification. FASEB J 1995;9:576-96.
5. Thiel G, Ekici M, Rössler OG. Regulation of cellular proliferation, differentiation and cell death by activated Raf. Cell Commun Signal 2009;7:8.
6. Sharma PS, Sharma R, Tyagi T. Receptor tyrosine kinase inhibitors as potent weapons in war against cancers. Curr Pharm Des 2009;15:758-76.
7. Roskoski R Jr. Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 2005;331:1-14.
8. Nolen B, Taylor S, Ghosh G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 2004;15:661-75.
9. Becker W, Heukelbach J, Kentrup H, Joost HG. Molecular cloning and characterization of a novel mammalian protein kinase harboring a homology domain that defines a subfamily of serine/threonine kinases. Eur J Biochem 1996;235:736-43.
10. Wang YL, Wang J, Chen X, Wang ZX, Wu JW. Crystal structure of the kinase and UBA domains of SNRK reveals a distinct UBA binding mode in the AMPK family. Biochem Biophys Res Commun 2018;495:1-6.
11. Jaleel M, McBride A, Lizcano JM, Deak M, Toth R, et al. Identification of the sucrose non-fermenting related kinase SNRK, as a novel LKB1 substrate. FEBS Lett 2005;579:1417-23.
12. Rines AK, Burke MA, Fernandez RP, Volpert OV, Ardehali H. Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin-binding protein-dependent reduction of β-catenin. FASEB J 2012;26:4685-95.
13. Cossette SM, Bhute VJ, Bao X, Harmann LM, Horswill MA, et al. Sucrose nonfermenting-related kinase enzyme-mediated rho-associated kinase signaling is responsible for cardiac function. Circ Cardiovasc Genet 2016;9:474-86.
14. Thirugnanam K, Cossette SM, Lu Q, Chowdhury SR, Harmann LM, et al. Cardiomyocyte-specific snrk prevents inflammation in the heart. J Am Heart Assoc 2019;8:e012792.
15. Cossette SM, Gastonguay AJ, Bao X, Lerch-Gaggl A, Zhong L, et al. Sucrose non-fermenting related kinase enzyme is essential for cardiac metabolism. Biol Open 2014;4:48-61.
16. Rines AK, Chang HC, Wu R, Sato T, Khechaduri A, et al. Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling. Nat Commun 2017;8:14095.
17. Li J, An R, Lai S, Li L, Liu S, et al. Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue. Mol Metab 2019;28:26-35.
18. Li J, Feng B, Nie Y, Jiao P, Lin X, et al. Sucrose nonfermenting-related kinase regulates both adipose inflammation and energy homeostasis in mice and humans. Diabetes 2018;67:400-11.
19. Li Y, Nie Y, Helou Y, Ding G, Feng B, et al. Identification of sucrose non-fermenting-related kinase (SNRK) as a suppressor of adipocyte inflammation. Diabetes 2013;62:2396-409.
20. Pramanik K, Chun CZ, Garnaas MK, Samant GV, Li K, et al. Dusp-5 and Snrk-1 coordinately function during vascular development and disease. Blood 2009;113:1184-91.
21. Lu Q, Xie Z, Yan C, Ding Y, Ma Z, et al. SNRK (sucrose nonfermenting 1-related kinase) promotes angiogenesis in vivo. Arterioscler Thromb Vasc Biol 2018;38:373-85.
22. Lu Q, Ma Z, Ding Y, Bedarida T, Chen L, et al. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis. Nat Commun 2019;10:2145.
23. Hopp EE, Cossette SM, Kumar SN, Eastwood D, Ramchandran R, et al. Sucrose non-fermenting related kinase expression in ovarian cancer and correlation with clinical features. Cancer Invest 2017;35:456-62.
24. Yoshida K, Yamada M, Nishio C, Konishi A, Hatanaka H. SNRK, a member of the SNF1 family, is related to low K[+]-induced apoptosis of cultured rat cerebellar granule neurons. Brain Res 2000;873:274-82.
25. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002;298:1912-34.
26. Bright NJ, Thornton C, Carling D. The regulation and function of mammalian AMPK-related kinases. Acta Physiol (Oxf) 2009;196:15-26.
27. Rider MH. The ubiquitin-associated domain of AMPK-related protein kinases allows LKB1-induced phosphorylation and activation. Biochem J 2006;394:e7-9.
28. Chen L, Jiao ZH, Zheng LS, Zhang YY, Xie ST, et al. Structural insight into the autoinhibition mechanism of AMP-activated protein kinase. Nature 2009;459:1146-9.
29. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 2004;101:3329-35.
30. Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem 2006;75:137-63.
31. Sapkota GP, Boudeau J, Deak M, Kieloch A, Morrice N, et al. Identification and characterization of four novel phosphorylation sites (Ser31, Ser325, Thr336 and Thr366) on LKB1/STK11, the protein kinase mutated in Peutz-Jeghers cancer syndrome. Biochem J 2002;362:481-90.
32. Sapkota GP, Kieloch A, Lizcano JM, Lain S, Arthur JS, et al. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth. J Biol Chem 2001;276:19469-82.
33. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-7.
34. Baas AF, Boudeau J, Sapkota GP, Smit L, Medema R, et al. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. EMBO J 2003;22:3062-72.
35. Boudeau J, Baas AF, Deak M, Morrice NA, Kieloch A, et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. EMBO J 2003;22:5102-14.
36. Xie Z, Dong Y, Zhang J, Scholz R, Neumann D, et al. Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol 2009;29:3582-96.
37. Boudeau J, Scott JW, Resta N, Deak M, Kieloch A, et al. Analysis of the LKB1-STRAD-MO25 complex. J Cell Sci 2004;117:6365-75.
38. Nakano H, Minami I, Braas D, Pappoe H, Wu X, et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. Elife 2017;6:e29330.
39. Bartelds B, Knoester H, Smid GB, Takens J, Visser GH, et al. Perinatal changes in myocardial metabolism in lambs. Circulation 2000;102:926-31.
40. Fisher DJ, Heymann MA, Rudolph AM. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am J Physiol 1980;238:H399-405.
41. Warshaw JB, Terry ML. Cellular energy metabolism during fetal development. II. Fatty acid oxidation by the developing heart. J Cell Biol 1970;44:354-60.
42. Werner JC, Sicard RE, Schuler HG. Palmitate oxidation by isolated working fetal and newborn pig hearts. Am J Physiol 1989;256:E315-21.
43. Piquereau J, Ventura-Clapier R. Maturation of Cardiac Energy Metabolism During Perinatal Development. Front Physiol 2018;9:959.
44. Kolwicz SC Jr, Purohit S, Tian R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 2013;113:603-16.
45. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Craig JC. Dual carbon-labeled isotope experiments using D-(6-14C) glucose and L-(1,2,3-13C3) lactate: a new approach for investigating human myocardial metabolism during ischemia. J Am Coll Cardiol 1985;5:1138-46.
46. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 1988;82:2017-25.
47. D’Souza K, Nzirorera C, Kienesberger PC. Lipid metabolism and signaling in cardiac lipotoxicity. Biochim Biophys Acta 2016;1861:1513-24.
48. Loirand G, Guérin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 2006;98:322-34.
49. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003;300:1574-7.
50. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003;278:45777-84.
51. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92:1023-33.
52. Bernstein RS, Grant N, Kipnis DM. Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without obesity or diabetes mellitus. Diabetes 1975;24:207-13.
53. Brook CG, Lloyd JK. Adipose cell size and glucose tolerance in obese children and effects of diet. Arch Dis Child 1973;48:301-4.
54. McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007;50:1707-15.
55. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000;43:1498-506.
56. Laforest S, Labrecque J, Michaud A, Cianflone K, Tchernof A. Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction. Crit Rev Clin Lab Sci 2015;52:301-13.
57. Ha EE, Bauer RC. Emerging roles for adipose tissue in cardiovascular disease. Arterioscler Thromb Vasc Biol 2018;38:e137-44.
58. Veilleux A, Houde VP, Bellmann K, Marette A. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Mol Endocrinol 2010;24:766-78.
59. Suthahar N, Meijers WC, Silljé HHW, de Boer RA. From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities. Curr Heart Fail Rep 2017;14:235-50.
60. Van Linthout S, Tschöpe C. Inflammation - cause or consequence of heart failure or both? Curr Heart Fail Rep 2017;14:251-65.
61. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009;29:1575-91.
62. Ko HJ, Zhang Z, Jung DY, Jun JY, Ma Z, et al. Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart. Diabetes 2009;58:2536-46.
63. Tikellis C, Thomas MC, Harcourt BE, Coughlan MT, Pete J, et al. Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am J Physiol Endocrinol Metab 2008;295:E323-30.
64. Song X, Kusakari Y, Xiao CY, Kinsella SD, Rosenberg MA, et al. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Am J Physiol Cell Physiol 2010;299:C1256-66.
65. Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol 2013;168:3160-72.
66. Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res 2016;118:1021-40.
67. Blüher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010;21:38-43.
68. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 2014;20:103-18.
69. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-49.
70. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-9.
72. Prabhudesai S, Koceja C, Dey A, Eisa-Beygi S, Leigh NR, et al. Cystathionine β-synthase is necessary for axis development in vivo. Front Cell Dev Biol 2018;6:14.
73. Eisa-Beygi S, Benslimane FM, El-Rass S, Prabhudesai S, Abdelrasoul MKA, et al. Characterization of endothelial cilia distribution during cerebral-vascular development in Zebrafish [ Danio rerio]. Arterioscler Thromb Vasc Biol 2018;38:2806-18.
74. Leigh NR, Schupp MO, Li K, Padmanabhan V, Gastonguay A, et al. Mmp17b is essential for proper neural crest cell migration in vivo. PLoS One 2013;8:e76484.
75. Pardanaud L, Yassine F, Dieterlen-Lievre F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 1989;105:473-85.
76. Chun CZ, Kaur S, Samant GV, Wang L, Pramanik K, et al. Snrk-1 is involved in multiple steps of angioblast development and acts via notch signaling pathway in artery-vein specification in vertebrates. Blood 2009;113:1192-9.
77. Eriksson J, Löfberg J. Development of the hypochord and dorsal aorta in the zebrafish embryo [Danio rerio]. J Morphol 2000;244:167-76.
78. Fouquet B, Weinstein BM, Serluca FC, Fishman MC. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev Biol 1997;183:37-48.
79. Sumanas S, Jorniak T, Lin S. Identification of novel vascular endothelial-specific genes by the microarray analysis of the zebrafish cloche mutants. Blood 2005;106:534-41.
80. Eilken HM, Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol 2010;22:617-25.
81. Uemura A, Kusuhara S, Katsuta H, Nishikawa S. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp Cell Res 2006;312:676-83.
82. Nessa A, Latif SA, Siddiqui NI, Hussain MA, Bhuiyan MR, et al. Angiogenesis-a novel therapeutic approach for ischemic heart disease. Mymensingh Med J 2009;18:264-72.
83. Mori J, Zhang L, Oudit GY, Lopaschuk GD. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure. J Mol Cell Cardiol 2013;63:98-106.
84. Gottlieb RA, Bernstein D. METABOLISM. Mitochondria shape cardiac metabolism. Science 2015;350:1162-3.
85. Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT, D’Antoni ML, et al. Revisiting cardiac cellular composition. Circ Res 2016;118:400-9.
86. Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010;2:914-23.
87. Pillai VB, Samant S, Sundaresan NR, Raghuraman H, Kim G, et al. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3. Nat Commun 2015;6:6656.
88. Pillai VB, Kanwal A, Fang YH, Sharp WW, Samant S, et al. Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice. Oncotarget 2017;8:34082-98.
89. Chen L, Chen R, Wang H, Liang F. Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol 2015;2015:508409.
91. Avizienyte E, Loukola A, Roth S, Hemminki A, Tarkkanen M, et al. LKB1 somatic mutations in sporadic tumors. Am J Pathol 1999;154:677-81.
92. Bignell GR, Barfoot R, Seal S, Collins N, Warren W, et al. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res 1998;58:1384-6.
93. Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-40.
94. Rowan A, Bataille V, MacKie R, Healy E, Bicknell D, et al. Somatic mutations in the Peutz-Jeghers [LKB1/STKII] gene in sporadic malignant melanomas. J Invest Dermatol 1999;112:509-11.
95. Qiu W, Schönleben F, Thaker HM, Goggins M, Su GH. A novel mutation of STK11/LKB1 gene leads to the loss of cell growth inhibition in head and neck squamous cell carcinoma. Oncogene 2006;25:2937-42.
96. Kim CJ, Cho YG, Park JY, Kim TY, Lee JH, et al. Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer 2004;40:136-41.
97. Powis G, Kirkpatrick L. Hypoxia inducible factor-1alpha as a cancer drug target. Mol Cancer Ther 2004;3:647-54.
98. Nie F, Yu XL, Wang XG, Tang YF, Wang LL, et al. Down-regulation of CacyBP is associated with poor prognosis and the effects on COX-2 expression in breast cancer. Int J Oncol 2010;37:1261-9.
99. Ning X, Sun S, Hong L, Liang J, Liu L, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 2007;5:1254-62.
100. Sun S, Ning X, Liu J, Liu L, Chen Y, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 2007;356:864-71.
